SRC - SRC proto-oncogene, non-receptor tyrosine kinase Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 701057
About SRC
Primary_assembly 10: 72,601,796-72,664,277 forward strand.Mmul_10:CM014345.1
This gene has 3 transcripts (splice variants), 261 orthologues and 32 paralogues.
SRC Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001261334.1 | NP_001248263.1 | proto-oncogene tyrosine-protein kinase Src |
SRC Protein Structure
SH3_Src
SH3_Src: cd12008 (87 - 142)
SH2_Src_Src
SH2_Src_Src: cd10365 (146 - 246)
PTKc_Src
PTKc_Src: cd05071 (259 - 535)
- 0
- 100
- 200
- 300
- 400
- 500
- 536 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
proto-oncogene tyrosine-protein kinase Src |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10181 | Dasatinib | Inhibitor | 99.85% | Yes |
| HY-12047 | Ponatinib | Inhibitor | 99.67% | Yes |
| HY-10158 | Bosutinib | Inhibitor | 99.96% | Yes |
| HY-10181A | Dasatinib hydrochloride | Inhibitor | 99.67% | Yes |
| HY-10340 | Tirbanibulin | Inhibitor | 99.45% | Unkown |
| HY-10209 | Masitinib | Inhibitor | 99.94% | Yes |
| HY-108766 | Ponatinib hydrochloride | Inhibitor | 99.76% | Yes |
| HY-10181B | Dasatinib monohydrate | Inhibitor | 99.58% | Yes |
| HY-10209A | Masitinib mesylate | Inhibitor | 99.98% | Yes |
| HY-10158A | Bosutinib hydrate | Inhibitor | 99.97% | Yes |
| HY-10340B | Tirbanibulin Mesylate | Inhibitor | 99.94% | Unkown |
Clinical Phase
Bioactive Molecules
(18)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-10234 | Saracatinib | Inhibitor | 99.23% | Phase 3 |
| HY-10234A | Saracatinib difumarate | Inhibitor | 99.93% | Phase 3 |
| HY-10340A | Tirbanibulin dihydrochloride | Inhibitor | 98.02% | Phase 3 |
| HY-13024 | Rebastinib | Inhibitor | 99.84% | Phase 2 |
| HY-50868 | Bafetinib | Inhibitor | 99.18% | Phase 2 |
| HY-59047 | Tolimidone | Activator | 99.98% | Phase 2 |
| HY-32718 | Pelitinib | Inhibitor | 99.13% | Phase 2 |
| HY-15323 | PRT062607 Hydrochloride | Inhibitor | 98.07% | Phase 2 |
| HY-10987A | ENMD-2076 | Inhibitor | 99.99% | Phase 2 |
| HY-10186 | TG 100801 | Inhibitor | 98.61% | Phase 2 |
| HY-10987 | ENMD-2076 Tartrate | Inhibitor | 99.66% | Phase 2 |
| HY-10187 | TG 100801 Hydrochloride | Inhibitor | / | Phase 2 |
| HY-157442 | GLPG3312 | Inhibitor | 98.63% | Phase 1 |
| HY-10032 | PF 477736 | Inhibitor | 99.04% | Phase 1 |
| HY-111787 | Elzovantinib | Inhibitor | 99.93% | Phase 1 |
| HY-15749 | XL228 | Inhibitor | 99.64% | Phase 1 |
| HY-112809 | GSK2646264 | Inhibitor | 99.74% | Phase 1 |
| HY-112314 | AZD0424 | Inhibitor | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P991664 | AG01 | Inhibitor | 95.10% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(266)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13805 | PP2 | Inhibitor | 98.34% | Unkown |
| HY-15176A | Pyridostatin hydrochloride | Inhibitor | 99.95% | Unkown |
| HY-N0752 | Scutellarein | Inhibitor | 99.39% | Unkown |
| HY-12299 | WH-4-023 | Inhibitor | 99.87% | Unkown |
| HY-101053 | Src Inhibitor 1 | Inhibitor | 99.97% | Unkown |
| HY-B0789 | SU6656 | Inhibitor | 99.01% | Unkown |
| HY-112096 | eCF506 | Inhibitor | 99.77% | Unkown |
| HY-N7264 | 7α-Hydroxycholesterol | 99.99% | Unkown | |
| HY-N0031 | Plantamajoside | 99.80% | Unkown | |
| HY-W062835 | CGP77675 | Inhibitor | 99.46% | Unkown |
| HY-135299 | CH6953755 | Inhibitor | 99.75% | Unkown |
| HY-12072 | Lck Inhibitor | Inhibitor | 99.65% | Unkown |
| HY-11011 | A-770041 | Inhibitor | 99.89% | Unkown |
| HY-15764 | A 419259 | Inhibitor | 99.88% | Unkown |
| HY-130254 | CSK-IN-1 | Inhibitor | 98.61% | Unkown |
| HY-15764A | A 419259 trihydrochloride | Inhibitor | 98.28% | Unkown |
| HY-10395 | PD173955 | Inhibitor | 99.12% | Unkown |
| HY-132166 | Velzatinib | Inhibitor | 99.40% | Unkown |
| HY-13804 | PP1 | Inhibitor | 99.57% | Unkown |
| HY-15176B | Pyridostatin TFA | Inhibitor | 99.17% | Unkown |
| HY-136848 | SM1-71 | Inhibitor | 96.09% | Unkown |
| HY-13942 | 1-NM-PP1 | Inhibitor | 98.93% | Unkown |
| HY-N0202 | Atractylenolide II | Inhibitor | 99.89% | Unkown |
| HY-112852 | TL02-59 | Inhibitor | 99.86% | Unkown |
| HY-13941 | 1-Naphthyl PP1 | Inhibitor | 99.36% | Unkown |
| HY-W040055 | Neopterin | Inhibitor | 99.95% | Unkown |
| HY-139147 | iHCK-37 | Inhibitor | 99.52% | Unkown |
| HY-122113 | PD173952 | Inhibitor | 99.58% | Unkown |
| HY-10372 | PP121 | Inhibitor | 99.51% | Unkown |
| HY-P3279 | EPQpYEEIPIYL | Activator | 99.49% | Unkown |
| HY-118144 | PD166326 | Inhibitor | 99.99% | Unkown |
| HY-121705 | Propionyl-L-carnitine | Activator | 95.0% | Unkown |
| HY-18303 | AMG-47a | Inhibitor | 99.19% | Unkown |
| HY-100434 | PD-161570 | Inhibitor | 99.82% | Unkown |
| HY-78263 | MNS | Inhibitor | 99.55% | Unkown |
| HY-108318 | RK-24466 | Inhibitor | 99.91% | Unkown |
| HY-148385 | Ganglioside GM2 | Activator | 98.0% | Unkown |
| HY-N0442 | 5-O-Methylvisammioside | Inhibitor | 99.90% | Unkown |
| HY-N0701 | (-)-Asarinin | Inhibitor | 99.74% | Unkown |
| HY-159480 | AD1058 | Inhibitor | 98.11% | Unkown |
| HY-101963 | AD80 | Inhibitor | 99.88% | Unkown |
| HY-108488 | KB SRC 4 | Inhibitor | 99.22% | Unkown |
| HY-155657 | BT424 | Inhibitor | 98.89% | Unkown |
| HY-136605 | DGY-06-116 | Inhibitor | 98.62% | Unkown |
| HY-N0909 | Notoginsenoside R2 | Inhibitor | 99.80% | Unkown |
| HY-120417 | JP-153 | Inhibitor | 99.45% | Unkown |
| HY-101795 | Larixyl acetate | Inhibitor | 99.44% | Unkown |
| HY-163144 | DAS-5-oCRBN | Degrader | 99.21% | Unkown |
| HY-18622 | PP58 | Inhibitor | 98.70% | Unkown |
| HY-15805 | KIN-8194 | Inhibitor | 99.26% | Unkown |
| HY-131669 | Dasatinib metabolite M6 | Inhibitor | 99.39% | Unkown |
| HY-10181S | Dasatinib-d8 | Inhibitor | 99.15% | Unkown |
| HY-112182 | UM-164 | Inhibitor | 98.74% | Unkown |
| HY-146127A | Grb2 SH2 domain inhibitor 1 TFA | Inhibitor | 99.62% | Unkown |
| HY-13561 | AZM475271 | Inhibitor | 99.89% | Unkown |
| HY-108016 | Peruvoside | Inhibitor | 99.32% | Unkown |
| HY-10185 | TG 100572 Hydrochloride | Inhibitor | 98.76% | Unkown |
| HY-107024 | Osteogenic Growth Peptide (10-14) | Inhibitor | 99.51% | Unkown |
| HY-103274 | PD180970 | Inhibitor | 99.27% | Unkown |
| HY-107447 | N-Deshydroxyethyl Dasatinib | Ligand | 97.19% | Unkown |
| HY-13314 | Tesevatinib | Inhibitor | 99.41% | Yes |
| HY-112291 | SB 220025 | Inhibitor | 99.90% | Unkown |
| HY-N4201 | β-Hydroxyisovalerylshikonin | Inhibitor | 99.83% | Unkown |
| HY-127002 | Squarunkin A | Inhibitor | 99.49% | Unkown |
| HY-15176C | Pyridostatin trihydrochloride | Inhibitor | 99.85% | Unkown |
| HY-N6596 | 7-Hydroxy-4H-chromen-4-one | Inhibitor | 99.85% | Unkown |
| HY-15814 | HG-7-85-01 | Inhibitor | 98.14% | Unkown |
| HY-137345 | DB-3-291 | Degrader | 99.08% | Unkown |
| HY-120595 | JNJ-49095397 | Inhibitor | 99.55% | Unkown |
| HY-108485 | Damnacanthal | Inhibitor | 99.40% | Unkown |
| HY-N4127 | 3'-Demethylnobiletin | 99.98% | Unkown | |
| HY-13342AS | Apatinib-d8 free base | 92.5% | Unkown | |
| HY-P6442 | Chemerin15 | Inhibitor | 99.65% | Unkown |
| HY-137342 | SB1-G-187 | Degrader | 98.70% | Unkown |
| HY-13941B | 1-Naphthyl PP1 hydrochloride | Inhibitor | 99.83% | Unkown |
| HY-10644 | Lck inhibitor 2 | Inhibitor | 99.73% | Unkown |
| HY-120213 | YH-306 | Inhibitor | 98.34% | Unkown |
| HY-137918 | TGF-βRI inhibitor 3 | Inhibitor | 99.16% | Unkown |
| HY-155582 | BLK degrader 1 | Degrader | 98.94% | Unkown |
| HY-N7160 | 2-Hydroxy-3-methylanthraquinone | Inhibitor | 99.60% | Unkown |
| HY-132150A | HPK1-IN-2 dihydrochloride | Inhibitor | 97.09% | Unkown |
| HY-15324 | PRT062607 acetate | Inhibitor | 99.83% | Unkown |
| HY-W013857 | Lavendustin C | Inhibitor | 98.17% | Unkown |
| HY-18507 | AD57 | Inhibitor | 98.27% | Unkown |
| HY-P1377A | Caffeic acid-pYEEIE TFA | 98.47% | Unkown | |
| HY-176892A | Papaveroline hydrochloride | Inhibitor | 99.04% | Unkown |
| HY-N0046 | Notoginsenoside Fe | Inhibitor | 99.99% | Unkown |
| HY-18623 | VI 16832 | Ligand | 99.09% | Unkown |
| HY-111187 | KX2-361 | Inhibitor | 99.09% | Unkown |
| HY-W744699 | Larixol | Inhibitor | 95.52% | Unkown |
| HY-125028 | Hck-IN-1 | Inhibitor | 98.10% | Unkown |
| HY-163469 | SRC-3-IN-2 | Inhibitor | 96.32% | Unkown |
| HY-P1111 | Lyn peptide inhibitor | Inhibitor | 99.35% | Unkown |
| HY-136849 | TL13-68 | Inhibitor | 98.31% | Unkown |
| HY-122949 | Momordicine I | Inhibitor | 97.0% | Unkown |
| HY-112345 | PD-089828 | Inhibitor | 98.07% | Unkown |
| HY-175451 | MRT-10350 | Degrader | 99.10% | Unkown |
| HY-137343 | DB-0646 | Degrader | 98.0% | Unkown |
| HY-P2547A | Tyrosine Kinase Peptide 1 acetate | 99.51% | Unkown | |
| HY-102073 | TG53 | Inhibitor | 98.6% | Unkown |
| HY-P10665 | pYEEI | Inhibitor | 99.01% | Unkown |
| HY-12847 | CCT241161 | Inhibitor | 99.77% | Unkown |
| HY-148066 | DB0662 | Degrader | 99.66% | Unkown |
| HY-123298 | Chrysotoxine | Inhibitor | 99.52% | Unkown |
| HY-176461 | Pro-Dasatinib | Inhibitor | / | Unkown |
| HY-147314 | HIV-IN-6 | 98.14% | Unkown | |
| HY-156914 | IGF-1R/SRC-IN-1 | Inhibitor | 99.86% | Unkown |
| HY-15764G | A 419259 (GMP) | Inhibitor | / | Unkown |
| HY-162676 | SJ45566 | Degrader | 98.41% | Unkown |
| HY-10181G | Dasatinib (GMP) | Inhibitor | / | Unkown |
| HY-180888 | Lck-IN-5 | Inhibitor | 98.09% | Unkown |
| HY-179433 | PROTAC AR Degrader-12 | Inhibitor | / | Unkown |
| HY-12047S | Ponatinib-d8 | Inhibitor | 99.16% | Unkown |
| HY-138202 | Lck-IN-1 | Inhibitor | 98.54% | Unkown |
| HY-155587 | Hydroxy-PP | Inhibitor | 99.66% | Unkown |
| HY-176892 | Papaveroline | Inhibitor | / | Unkown |
| HY-P11147 | IL13Rα2 D1 | Inhibitor | 99.17% | Unkown |
| HY-123506 | Fenlean | Inhibitor | 99.56% | Unkown |
| HY-10158S | Bosutinib-d8 | Inhibitor | ≥99.0% | Unkown |
| HY-16906 | T338C Src-IN-2 | Inhibitor | 98.41% | Unkown |
| HY-116028 | 15-deoxy-Δ12,14-Prostaglandin D2 | Activator | 98.0% | Unkown |
| HY-153556 | GW297361 | Inhibitor | 98.13% | Unkown |
| HY-16905 | T338C Src-IN-1 | Inhibitor | / | Unkown |
| HY-13805R | PP2 (Standard) | Inhibitor | 99.05% | Unkown |
| HY-10184 | TG 100572 | Inhibitor | / | Unkown |
| HY-117123 | Convulxin | Activator | / | Unkown |
| HY-18237 | KX1-004 | Inhibitor | 99.75% | Unkown |
| HY-10181S1 | Dasatinib-d4 | Inhibitor | 97.54% | Unkown |
| HY-118105 | RK-20448 | Inhibitor | 99.38% | Unkown |
| HY-10158S1 | Bosutinib-13C,d3 | Inhibitor | / | Unkown |
| HY-181050 | DFCI-002-06 | Degrader | / | Unkown |
| HY-112852A | TL02-59 dihydrochloride | Inhibitor | / | Unkown |
| HY-157998 | mG2N001 | / | Unkown | |
| HY-P2547 | Tyrosine Kinase Peptide 1 | / | Unkown | |
| HY-112404 | BCR-ABL-IN-13 | Inhibitor | 99.86% | Unkown |
| HY-183103 | PDD-87 | Inhibitor | / | Unkown |
| HY-175281 | SJ11646 | Degrader | / | Unkown |
| HY-121849 | KL-1156 | Inhibitor | / | Unkown |
| HY-172096 | cSRC/BCR-ABL-IN-1 | Inhibitor | / | Unkown |
| HY-161687 | Cisplatin/Dasatinib prodrug-1 | Inhibitor | / | Unkown |
| HY-10181GL | Dasatinib (GMP Like) | Inhibitor | / | Unkown |
| HY-116028S1 | 15-deoxy-Δ12,14-Prostaglandin D2-d4 | Activator | / | Unkown |
| HY-175809 | SRT6 | Inhibitor | / | Unkown |
| HY-176194 | Antifibrotic agent 1 | Inhibitor | / | Unkown |
| HY-10363 | AP 24149 | Inhibitor | / | Unkown |
| HY-18692 | Multi-kinase-IN-12 | Inhibitor | / | Unkown |
| HY-P1111A | Lyn peptide inhibitor TFA | Inhibitor | / | Unkown |
| HY-100824 | PP2 Analog | Inhibitor | / | Unkown |
| HY-125718 | MLS-2384 free base | Inhibitor | / | Unkown |
| HY-101447 | SI-2 | Inhibitor | / | Unkown |
| HY-163278 | Lck-IN-2 | Inhibitor | / | Unkown |
| HY-150026 | Multi-kinase-IN-2 | Inhibitor | / | Unkown |
| HY-136699 | Excisanin A | Inhibitor | / | Unkown |
| HY-P1200 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | Inhibitor | / | Unkown |
| HY-P3743 | p60c-src Substrate | / | Unkown | |
| HY-13314A | Tesevatinib tosylate | Inhibitor | / | Unkown |
| HY-180928 | LCK degrader-3 | Degrader | / | Unkown |
| HY-175280 | Lck degrader-1 | Degrader | / | Unkown |
| HY-122860 | SKLB-C05 | / | Unkown | |
| HY-P10527 | CSK substrate | / | Unkown | |
| HY-175437 | MRT-7612 | Degrader | / | Unkown |
| HY-P2413 | Ac-PPPHPHARIK-NH2 | Inhibitor | / | Unkown |
| HY-149921 | Antiangiogenic agent 3 | Inhibitor | / | Unkown |
| HY-162291 | Lck-IN-3 | Inhibitor | / | Unkown |
| HY-E70726 | FYN Y531F Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-185227 | EphB4-IN-1 | Inhibitor | / | Unkown |
| HY-112393 | TX-1918 | Inhibitor | / | Unkown |
| HY-183584 | ARN25699 | Inhibitor | / | Unkown |
| HY-108487 | N-Acetyl-O-phosphono-Tyr-Glu dipentylamide | Inhibitor | / | Unkown |
| HY-135216 | Antiproliferative agent-54 | Inhibitor | / | Unkown |
| HY-181732 | PROTAC TG2 Degrader-3 | Modulator | / | Unkown |
| HY-E70725 | FRK Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-178950 | Hck-IN-3 | Inhibitor | / | Unkown |
| HY-175916 | LCK ligand-1 | Ligand | / | Unkown |
| HY-10188 | SKS-927 | Inhibitor | / | Unkown |
| HY-P0200 | RR-SRC | / | Unkown | |
| HY-160167 | Birelentinib | Inhibitor | / | Unkown |
| HY-175193 | N-Deshydroxyethyl Dasatinib-C3-NH2 | Inhibitor | / | Unkown |
| HY-114980 | BMS-279700 | Inhibitor | / | Unkown |
| HY-162413 | (R)-LW-Srci-8 | Inhibitor | / | Unkown |
| HY-12299G | WH-4-023 (GMP) | Inhibitor | / | Unkown |
| HY-112096S | eCF506-d5 | Inhibitor | / | Unkown |
| HY-115723 | Antiallergic agent-1 | Inhibitor | / | Unkown |
| HY-128397 | CpCDPK1/TgCDPK1-IN-1 | Inhibitor | / | Unkown |
| HY-182293 | BTK-IN-48 | Inhibitor | / | Unkown |
| HY-163468 | SRC-3-IN-1 | Inhibitor | / | Unkown |
| HY-125387 | TOP1210 | / | Unkown | |
| HY-175463 | LCK degrader-2 | Degrader | / | Unkown |
| HY-178120 | Lck-IN-4 | Inhibitor | / | Unkown |
| HY-138195 | NEO212 | Inhibitor | / | Unkown |
| HY-125142 | AP-24567 | Inhibitor | / | Unkown |
| HY-112335 | Lck Inhibitor III | Inhibitor | / | Unkown |
| HY-127002A | Squarunkin A hydrochloride | Inhibitor | / | Unkown |
| HY-W062835A | CGP77675 hydrate | Inhibitor | / | Unkown |
| HY-112369 | LDDN-0003499 | Inhibitor | / | Unkown |
| HY-112448 | Lck-IN-6 | Inhibitor | / | Unkown |
| HY-123394 | AP-22161 | Inhibitor | / | Unkown |
| HY-168901 | Hck-IN-2 | Inhibitor | / | Unkown |
| HY-10158AR | Bosutinib hydrate (Standard) | Inhibitor | / | Unkown |
| HY-15268 | PP487 | Inhibitor | / | Unkown |
| HY-W745090 | Isomaltulose monohydrate | Inhibitor | / | Unkown |
| HY-P1200A | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA | Inhibitor | / | Unkown |
| HY-168187 | Src Inhibitor 3 | Inhibitor | / | Unkown |
| HY-131931A | Lysoganglioside-GM1 ammonium | Inhibitor | / | Unkown |
| HY-121828 | TX-1123 | Inhibitor | / | Unkown |
| HY-W844558 | Protein kinase inhibitor 11 | Inhibitor | 98.28% | Unkown |
| HY-18507A | AD57 hydrochloride | Inhibitor | / | Unkown |
| HY-175845 | Scr-IN-2 | Inhibitor | / | Unkown |
| HY-P3771 | p60c-src substrate II, phosphorylated | / | Unkown | |
| HY-P1377 | Caffeic acid-pYEEIE | / | Unkown | |
| HY-180938 | Fyn-IN-1 | Inhibitor | / | Unkown |
| HY-170958 | Scr-IN-1 | Inhibitor | / | Unkown |
| HY-139890 | DC-Srci-6649 | Inhibitor | / | Unkown |
| HY-101268 | CHMFL-ABL-053 | Inhibitor | / | Unkown |
| HY-W769935 | 5-POHSA | Modulator | / | Unkown |
| HY-179948 | BTK-IN-45 | Inhibitor | / | Unkown |
| HY-170971 | Src Inhibitor 4 | Inhibitor | / | Unkown |
| HY-146014 | Multi-kinase-IN-1 | Inhibitor | / | Unkown |
| HY-157497 | DA5-HTL | Inhibitor | 98.69% | Unkown |
| HY-P2372 | P60v-src(137-157) | Inhibitor | / | Unkown |
| HY-157290 | HL403 | Inhibitor | / | Unkown |
| HY-P3773 | p60c-src substrate II | / | Unkown | |
| HY-168893 | K882 | Inhibitor | / | Unkown |
| HY-P10372 | pFYN peptide | / | Unkown | |
| HY-180834 | Tyrosine kinase-IN-11 | Inhibitor | 98.75% | Unkown |
| HY-182614 | BJ-2302 | Inhibitor | / | Unkown |
| HY-131931 | Lysoganglioside-GM1 potassium | Inhibitor | / | Unkown |
| HY-110367 | LCB 03-0110 dihydrochloride | Inhibitor | / | Unkown |
| HY-176225 | BY13 | Degrader | / | Unkown |
| HY-E70862 | Src-ZAP70 Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-176367 | Multi kinase ligand 4 | Inhibitor | / | Unkown |
| HY-177272 | HPK1-IN-61 | Inhibitor | / | Unkown |
| HY-W714853 | (+)-Theta-cypermethrin | Ligand | / | Unkown |
| HY-162879 | FAK inhibitor 7 | Inhibitor | / | Unkown |
| HY-175298 | STAT-3/c-Src-IN-1 | Inhibitor | / | Unkown |
| HY-125500 | TOP1362 | Inhibitor | / | Unkown |
| HY-110367A | LCB 03-0110 | Inhibitor | / | Unkown |
| HY-120622 | BMS-243117 | Inhibitor | / | Unkown |
| HY-D3058 | FITC-amide-C2 Lck inhibitor 2 | Inhibitor | / | Unkown |
| HY-N14273 | Hibarimicin C | Inhibitor | / | Unkown |
| HY-N0442R | 5-O-Methylvisammioside (Standard) | Inhibitor | / | Unkown |
| HY-18909 | Multi-kinase-IN-11 | Inhibitor | / | Unkown |
| HY-N14279 | Hibarimicin G | Inhibitor | / | Unkown |
| HY-164527 | Si306 | Inhibitor | / | Unkown |
| HY-N15076 | Herbimycin B | Inhibitor | / | Unkown |
| HY-160930 | TOP1288 | Inhibitor | / | Unkown |
| HY-10234S | Saracatinib-d3 | Inhibitor | / | Unkown |
| HY-169670 | Protein kinase inhibitor 13 | Inhibitor | / | Unkown |
| HY-122585 | proMMP-9 inhibitor-3c | Inhibitor | / | Unkown |
| HY-32718S | Pelitinib-d6 | / | Unkown | |
| HY-136622 | A-420983 | Inhibitor | / | Unkown |
| HY-133184 | Aminogenistein | Inhibitor | / | Unkown |
| HY-W700620 | Hydroxymethyl dasatinib | Inhibitor | 99.92% | Unkown |
| HY-N14271 | Hibarimicin B | Inhibitor | / | Unkown |
| HY-W994722 | ISO24 | Ligand | / | Unkown |
| HY-112852S | TL02-59-d5 | / | Unkown | |
| HY-N14618 | Rhodomycin A | Inhibitor | / | Unkown |
| HY-178014 | SIK1-IN-1 | Inhibitor | / | Unkown |
| HY-125064 | AP22408 | Inhibitor | / | Unkown |
| HY-N12166 | 2,3,4,6,8-Pentahydroxy-1-methylxanthone | Inhibitor | / | Unkown |
| HY-N14689 | Hibarimicin D | Inhibitor | / | Unkown |
| HY-171217 | TG-100435 | Inhibitor | / | Unkown |
| HY-112291A | SB 220025 (tri(hydrochloride)) | Inhibitor | / | Unkown |
| HY-N14267 | Hibarimicin A | Inhibitor | / | Unkown |
| HY-164530 | SKLB646 | Inhibitor | / | Unkown |
| HY-171218 | CGP062464 | Inhibitor | / | Unkown |